Catena Biosciences
Pre-clinicalOur breakthrough protein conjugation offers potential for therapeutic creation with greater speed, stability, selectivity, and scalability than current approaches.
Founded
2019
Focus
AntibodiesBiologicsDrug Delivery
About
Our breakthrough protein conjugation offers potential for therapeutic creation with greater speed, stability, selectivity, and scalability than current approaches.
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile